Study of KD026 in Combination With Metformin in Subjects With Type 2 Diabetes Mellitus

PHASE2CompletedINTERVENTIONAL
Enrollment

121

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

KD026

Dosed in combination

DRUG

Placebo

Dosed in combination

DRUG

Metformin

Drug prescribed by each subject's prescribing physician

Trial Locations (10)

23507

Clinical Research Associates of Tidewater, Norfolk

27265

High Point Clinical Trials Center, High Point

29464

Coastal Carolina Research Center, Mt. Pleasant

33134

Clinical Research of South Florida, Coral Gables

33186

Med Research of Florida, LLC, Miami

35216

Achieve Clinical Research, LLC, Birmingham

77074

Clinical Trial Network, Houston

90036

Axis Clinical Trials, Los Angeles

90057

National Research Institute, Los Angeles

91307

Infosphere Clinical Research, Inc, West Hills

Sponsors
All Listed Sponsors
lead

Response Pharmaceuticals

INDUSTRY

NCT02434744 - Study of KD026 in Combination With Metformin in Subjects With Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter